menu search

Altamira therapeutics to report bentrio clinical data, in house dust mite and grass pollen allergic rhinitis, at feb. 25 aaaai annual meet-ing

House dust mite study shows statistically significant reduction in symptoms vs. no protection Grass pollen study shows faster onset of action and supe...

February 14, 2023, 8:47 am

3 undervalued stocks with momentum in 2023

#Morningstar #Stockytobuy #GrowthStocks These stocks have soared this year but we think they have more upside potential. 0:00 Introduction 0:50 Scotts...

February 14, 2023, 8:10 am

Electric vehicle (ev) powertrain market is set to cross us$ 112 billion by 2033 | future market insights, inc.

Chinese EV Powertrain Market it is still poised to grow at a rate of 21.3% through 2033. the overall demand for EV powertrains in particular may exper...

February 14, 2023, 12:30 am

Us fed 'insider' timiraos is warning of a potential upside surprise in january us cpi data

If US equity market movements are anything to go by a downside surprise seems the most likely:

...

February 13, 2023, 11:09 pm

Noor capital’s mohammed jabri joins tradeultra as ceo

TradeUltra, a ...

February 13, 2023, 8:30 pm

Uae’s central bank to issue cbdc under new fit programme

The Central Bank of the United Arab Emirates (CUBUAE) will launch a central bank digital currency (C...

February 13, 2023, 1:50 pm

Technical pressure could drag biotech lower

The shares of mirati Therapeutics Inc (NASDAQ:MRTX) have been pulling back on the charts this month, af...

February 13, 2023, 1:24 pm

Us fed 'insider' timiraos asks what if no landing, hard or soft, & us economy accelerates

A weekend piece in the Wall Street Journal from noted Fed whisperer Nick Timiraos

  • ...

    February 12, 2023, 11:20 pm

Price target aim on target

Target is a 55-year dividend aristocrat champion with an admirable 5-year dividend growth rate of 10.5%...

February 12, 2023, 8:35 pm

Here's exactly how abbvie stock can beat the market in 2023

Don't think the challenges for Humira doom AbbVie to a sub-par stock performance this year....

February 11, 2023, 6:00 am

Abbvie's humira: the downfall won't be as 'draconian' as initially expected

AbbVie stock won at least one upgrade Friday after issuing long-awaited guidance for Humira for the fir...

February 10, 2023, 10:52 am

Sports-licensed merchandise market surges as sports grow in popularity: to reach us$ 56.67 billion by 2033 | future market insights, inc.

The global licensed sports merchandise market as a part of the global apparel, accessories, and luxury goods market, within the textiles, apparel, and...

February 10, 2023, 12:30 am

First abu dhabi bank says not currently evaluating offer for stanchart

First Abu Dhabi Bank (FAB), the United Arab Emirates' biggest lender, said on Friday it was not current...

February 9, 2023, 11:48 pm

Lightpath technologies, inc. (lpth) q2 2023 earnings call transcript

LightPath Technologies, Inc. (NASDAQ:LPTH ) Q2 2023 Earnings Conference Call February 9, 2023 5:00 PM ET Company Participants Sam Rubin - President an...

February 9, 2023, 8:47 pm

Wsj timiraos: atlanta fed wage tracker "trended lower in january"

Wall Street Journal's Timiraos is tweeting that the Atlanta Fed wage tracker shows the pace of growt...

February 9, 2023, 5:34 pm

Scottsmiracle-gro to hold fireside chat with wells fargo

MARYSVILLE, Ohio, Feb. 09, 2023 (GLOBE NEWSWIRE) — The Scotts miracle-Gro Company (NYSE: SMG), the wo...

February 9, 2023, 4:35 pm

Timiraos: the services industry is finding it easier to recruit and fill jobs.

Fresh off his interview with NY Fed President John Williams, WSJ Fedwatcher Nick Timiraos is back at...

February 9, 2023, 3:52 pm

Canopy growth to axe 800 jobs in canada among other cost-cutting measures

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) has announced a suite of cost-cutting measures across its Canadian business, including a reduction in i...

February 9, 2023, 2:49 pm

The end of abbvie's $200 billion monopoly won't sink the stock

The drugmaker is offering steep discounts on its immune-disease therapy Humira to protect market share ...

February 9, 2023, 12:58 pm

Do humira biosimilars threaten abbvie's dividend?

Generic competition will eat at Humira's roughly $20 billion in annual sales....

February 9, 2023, 9:10 am


Search within

Pages Search Results: